Prevention of stroke in patients with atrial fibrillation: a role of modern anticoagulants

被引：0
|
作者：
Anisimova, A. V. [1 ]
Gendlin, G. E.
Borisov, S. N.
机构：
[1] Pirogov Russian Natl Res Med Univ, Moscow, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2013年 / 113卷 / 09期
关键词：
cardioembolic stroke; atrial fibrillation; primary and secondary prevention; oral anticoagulant; warfarin; rivaroxaban; FACTOR XA INHIBITOR; RISK-FACTORS; RIVAROXABAN; WARFARIN; MANAGEMENT; APPENDAGE; SAFETY;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The review addresses the primary and secondary prevention of cardioembolic ischemic stroke, in particular, in patients with non-valvular atrial fibrillation. Indications and schemes of anticoagulation treatment, advantages in stroke prevention and difficulties in using of the common oral anticoagulant warfarin are discussed. The authors compare the mechanism of action, efficacy and safety of the peroral anticoagulant rivaroxaban with warfarin. Based on the results of large meta-analyses, it has been concluded that the efficacy of rivaroxaban is rather superior to warfarin, this drug has the same safety profile and is more convenient in use. During treatment, no laboratory monitoring of hemostasis indicators is needed. This drug can be recommended for prevention of cardioembolic stroke in patients with atrial fibrillation.
引用
收藏
页码：62 / 69
页数：8
相关论文
共 50 条
  • [1] Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
    Jalota, A.
    Scarabelli, T. M.
    Saravolatz, L.
    Bakhsh, M. U.
    Agrawal, P.
    Jalota, R.
    Chen-Scarabelli, C.
    Fuster, V.
    Halperin, J.
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (03) : 247 - 262
  • [2] Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
    Andreas Schäfer
    Ulrike Flierl
    Dominik Berliner
    Johann Bauersachs
    Cardiovascular Drugs and Therapy, 2020, 34 : 555 - 568
  • [3] New Anticoagulants for Prevention of Stroke in Patients with Atrial Fibrillation
    Viles-Gonzalez, Juan F.
    Fuster, Valentin
    Halperin, Jonathan L.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 (08) : 948 - 955
  • [4] Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
    Schaefer, Andreas
    Flierl, Ulrike
    Berliner, Dominik
    Bauersachs, Johann
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (04) : 555 - 568
  • [5] Novel anticoagulants in stroke prevention in patients with atrial fibrillation
    Diener, H. -C.
    JOURNAL OF NEUROLOGY, 2013, 260 : S4 - S5
  • [6] Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation
    A. Jalota
    T. M. Scarabelli
    L. Saravolatz
    M. U. Bakhsh
    P. Agrawal
    R. Jalota
    C. Chen-Scarabelli
    V. Fuster
    J. Halperin
    Cardiovascular Drugs and Therapy, 2014, 28 : 247 - 262
  • [7] Pharmacogenetics of anticoagulants used for stroke prevention in patients with atrial fibrillation
    Kampouraki, Emmanouela
    Kamali, Farhad
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (06) : 449 - 458
  • [8] Novel anticoagulants for stroke prevention in atrial fibrillation
    Baumhaekel, M.
    Schirmer, S. H.
    Boehm, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2010, 135 (46) : 2304 - 2308
  • [9] New anticoagulants for stroke prevention in atrial fibrillation
    Diener, H. C.
    Hajjar, K.
    Frank, B.
    Perrey, M.
    HERZ, 2012, 37 (04) : 370 - 377
  • [10] Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Senoo, Keitaro
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    CURRENT PROBLEMS IN CARDIOLOGY, 2014, 39 (09) : 319 - 344
12345